行情

CGIX

CGIX

CANCER GENETICS
NASDAQ

实时行情|Nasdaq Last Sale

2.720
-0.030
-1.09%
已收盘, 16:00 04/01 EDT
开盘
2.790
昨收
2.750
最高
2.960
最低
2.655
成交量
1.76万
成交额
--
52周最高
9.89
52周最低
1.920
市值
571.14万
市盈率(TTM)
-0.0118
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CGIX价格均价为3.000,最高价位3.000,最低价为3.000。

EPS

CGIX 新闻

更多
  • 波音深陷“泥潭”,机构和媒体是怎么看的?
  • 新浪财经-自媒体综合 · 35分钟前
  • 美联储疯狂注水欲拯救流动性危机 非农夜会否再现诡异行情?
  • 新浪财经综合 · 59分钟前
  • 英航或将暂停职8成员工 全球民航业今年将损失2520亿美元
  • 新浪财经 · 1小时前
  • CSI:ETF在稳定市场中的作用
  • 新浪财经综合 · 2小时前

所属板块

医疗设施与服务
-3.84%
医疗保健提供商与服务
-4.36%

热门股票

代码
价格
涨跌幅

CGIX 简况

Cancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services and molecular markers. Through its subsidiary, the Company offers preclinical test systems. The Company offers discovery services to the pharmaceutical industry, biotechnology companies and academic research centers. The Company provides the tools and testing methods for companies and researchers to identify new molecular- and biomarker-based indicators for disease and to determine the pharmacogenomics, toxicity and efficacy of therapeutic candidate compounds. Its discovery services include development of both xenograft and syngeneic animal models, toxicology and genetic toxicology services, pharmacology testing, pathology services, and validation of biomarkers for diseases including cancers. It also provides consulting, guidance and preparation of samples.
展开

微牛提供Cancer Genetics Inc(NASDAQ-CGIX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CGIX股票新闻,以帮助您做出投资决策。